Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Direct Acting Antivirals Uptake in Controlling Hepatitis C Epidemic and Modeling Interventions for Hepatitis C Elimination Among HIV-infected Persons in San Diego

NCT03551002 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03551002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03551002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Direct Acting Antivirals Uptake in Controlling Hepatitis C Epidemic and Modeling Interventions for Hepatitis C Elimination Among HIV-infected Persons in San Diego
Lead sponsor
University of California, San Diego
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 31, 2021
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, hepatitis c, chronic, hiv/aids